Congratulations, MDC!

In 1992, Detlev Ganten had the vision of creating a “German Cold Spring Harbor.” As one well-wisher wrote, this dream has become a reality. Here are some of the congratulatory messages that the MDC has received.

“I offer my most heartfelt congratulations to the MDC on this special anniversary. It is held in high regard within the Helmholtz Association for its scientific approach, which uses basic molecular research as the foundation for developing innovative clinical applications. Furthermore, the MDC and its outstanding scientists represent an important partner in numerous scientific collaborations in Berlin and in other parts of Germany as well as internationally. I wish the center continued success in the future – and that patients may continue to benefit.”

Prof. Otmar D. Wiestler, President of the Helmholtz Association




“We are proud to have the Max Delbrück Center for Molecular Medicine as a strong member of the EU-Life team. We wish them a happy 25th anniversary and many exciting scientific discoveries in the next 25 years.”

Jo Bury, Chairman of EU-LIFE and Managing Director of VIB (the Flanders Institute of Biotechnology)





“Twenty-five years of the MDC – that is not just a quarter of a century of top-flight, ‘Made-in-Berlin’ research, it is also 25 years spent achieving international recognition and biomedical excellence. And for this, you have every reason to be very proud! What’s more, it’s 25 years of productive partnership between the MDC and Charité, providing a foundation upon which joint appointments and projects in both research and infrastructure can be built. For this, we both have reason to be proud!

Let us now use the Berlin Institute of Health as an opportunity to consolidate basic research and clinical practice even further, so that in another 25 years we can look back and say: ‘We have created something really unique in Germany.’”

Prof. Karl Max Einhäupl, Chairman of the Executive Board of Charité – Universitätsmedizin Berlin and member of the BIH Board of Directors



“My family taught me that there is an important connection between art and science. My father, who is a Professor at the Scripps Research Institute in San Diego, always said to me that they require a similar creative mind. As an artist, I’m deeply intrigued in looking at the world scientifically. This connection was there for my grandfather as well, and to see the Jeanne Mammen paintings and all the other art on campus inspires me. It is quite unique! I wish the MDC a very happy birthday and many discoveries ahead!”

Lara Salmon, granddaughter of Max Delbrück




“The MDC and the Buch campus have undergone impressive development since I first set foot on the campus back in 1995. Founding director Detlev Ganten’s vision to create a ‘German Cold Spring Harbor’ has become a reality. The MDC’s scientific excellence is now recognized worldwide, and the relationship to the biotech industry that was established at the campus has now become common practice. Congratulations and keep up the good work!”

Dr. Rolf Zettl, Administrative Director of the Berlin Institute for Health (BIH)



“In the 25 years since its creation, the MDC has become one of the world’s leading institutions in the fields of molecular biology, molecular genetics, and molecular medicine. It combines basic research with new approaches in medical diagnosis and treatment in the best possible way. I wish the MDC continued groundbreaking and scientific success in the future!”

Prof. Walter Rosenthal, President of Friedrich Schiller University Jena
Scientific Director of the MDC from 2009–2014




“Many congratulations on your anniversary! For the past 17 years, we have been fortunate enough to enjoy a close relationship with the MDC – not only geographically, as immediate neighbors, but also scientifically. Our joint projects see us discuss and promote new ideas and technology on a daily basis. We wish you all the continued success going forward!”

Prof. Dorothea Fiedler and Prof. Volker Haucke, Board of Directors of the Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP)